Bargains! PROMOTIONS

Close Notification

Your cart does not contain any items

$318.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
26 January 2026
Bladder Cancer Breakthroughs: A Global Perspective on Diagnosis, Treatment, and Patient Care
Edited by:   , , , , , , , , ,
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   450g
ISBN:   9780443366321
ISBN 10:   0443366322
Pages:   404
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1. Epidemiology and risk factors of bladder cancer 2. Diagnosis approaches for bladder cancer 3. Role of hydrogel in bladder cancer treatment 4. Role of Nanoparticles in bladder cancer management 5. Role of Quantum dots in bladder cancer management 6. Nanomaterial based biomarkers in bladder cancer management 7. Role of nanorods in bladder cancer management 8. Role of liposomes in bladder cancer management 9. Role of artificial intelligence in bladder cancer management 10. Role of nanocomposite for bladder cancer management 11. Targeting treatment of bladder cancer employing aptamer conjugates 12. Surgical interventions for bladder cancer management 13. Image guided radiotherapy for bladder cancer management 14. Role of gene sequencing in bladder cancer 15. Addressing and overcoming resistance in bladder cancer treatment

Dr. Bhupendra Gopalbhai Prajapati is Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India, and serves as Adjunct Professor in the Department of Industrial Pharmacy at Silpakorn University, Thailand. His academic, research, and industry expertise focuses on lipid‑based formulations, nano‑ and microparticulate drug delivery systems, and strategies to enhance drug bioavailability. Dr. Prajapati has received several academic and professional honors recognizing excellence in teaching and research. He has made substantial scholarly contributions through research and review publications, book chapters, and edited volumes in pharmaceutical sciences. Actively engaged in postgraduate and doctoral mentoring, he supports research training in advanced drug delivery and formulation science. Dr. Prajapati also serves in editorial and section‑editor roles for international scientific publications, contributing to the advancement and quality of pharmaceutical research dissemination. Dr. Devesh U. Kapoor is Professor of Pharmaceutics at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, affiliated with Gujarat Technological University. His academic and research expertise centers on pharmaceutics, nanodrug delivery, and modified‑release drug delivery systems. Dr. Kapoor has made extensive scholarly contributions through research and review publications, book chapters, and edited volumes with international publishers. He is actively involved in postgraduate and doctoral research supervision in advanced drug delivery technologies. His editorial experience includes serving in senior editorial roles for international journals across pharmacology, pharmaceutics, and biomedical sciences, along with regular peer‑review activity for a wide range of scientific journals. Dr. Kapoor has also secured competitive research and academic development funding and is a frequent invited speaker at national scientific meetings, workshops, and academic programs. Dr. Abdullah AlAsmari was graduated from King Saud University (KSU) with a B.S. in Pharmaceutical Sciences in 2011. In 2013, Dr. AlAsmari joined Auburn University (AU), Harrison School of Pharmacy department of Drug Discovery and Development (DDD) to pursue his PhD under supervision of Dr. Jianzhong Shen and Dr. Amin. In 2017, Dr. AlAsmari returned to KSU with PhD degree and became an assistant professor in the department of Pharmacology & Toxicology. Now he has been promoted as Associate Professor and serving as Vice Dean for Programs and Initiatives at Graduate School at KSU. He is currently working on different funded projects, which aim to induce cardioprotection against different mechanisms that can induce cardiac damage. His research area includes: Cardiovascular Diseases, Mechanisms of cardiotoxicity induced by different anti-cancer drugs. Dr Abdullah has published more than 150 articles in different reputed and peer reviewed journals and several book chapters.

See Also